Baloxavir Marboxil for Influenza

Phase-Based Progress Estimates
2
Effectiveness
3
Safety
Medical Corporation Houmankai?Umezu?Clinic, Chikushino, JapanInfluenzaBaloxavir Marboxil - Drug
Eligibility
5 - 64
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing the efficacy of baloxavir marboxil in reducing the spread of influenza within households.

Eligible Conditions
  • Influenza

Treatment Effectiveness

Effectiveness Progress

2 of 3
This is further along than 85% of similar trials

Study Objectives

1 Primary · 13 Secondary · Reporting Duration: Baseline to Day 9 (9 Days)

Baseline
Percentage of IPs (<= 12 years old) Reporting each Palatability and Acceptability Response
Baseline and Day 9
Change From Baseline in Work Productivity and Activity Impairment According to Work Productivity and Activity Impairment (WPAI) plus Classroom Impairement Questions Score (IPs only)
Day 5
Symptomatic Transmission at the Household Level by Day 5
Symptomatic Transmission by Day 5
Virological Transmission at the Household Level by Day 5
Virological Transmission by Day 5
Day 9
Any Symptomatic Infection at the Household Level by Day 9
Any Symptomatic Infection by Day 9
Any Virological Infection at the Household Level by Day 9
Any Virological Infection by Day 9
Symptomatic Transmission by Day 9
Day 9
Tomography, X-Ray
Year 12
Percentage of IPs With Adverse Events (AEs)
Day 9
Change from baseline in health-related quality of life according to EuroQol 5 dimensions 5 (EQ-5D-5L; Appendix 3) questionnaire at Day 3 and Day 9 Visits (IPs only)

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Side Effects for

Study Drug Eligible
1%Diarrhea
1%Headache
This histogram enumerates side effects from a completed 2020 Phase 4 trial (NCT04141930) in the Study Drug Eligible ARM group. Side effects include: Diarrhea with 1%, Headache with 1%.

Trial Design

2 Treatment Groups

Baloxavir Marboxil
1 of 2
Placebo
1 of 2

Experimental Treatment

Non-Treatment Group

3160 Total Participants · 2 Treatment Groups

Primary Treatment: Baloxavir Marboxil · Has Placebo Group · Phase 3

Baloxavir Marboxil
Drug
Experimental Group · 1 Intervention: Baloxavir Marboxil · Intervention Types: Drug
Placebo
Drug
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Baloxavir marboxil
FDA approved

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline to day 9 (9 days)

Who is running the clinical trial?

Hoffmann-La RocheLead Sponsor
2,371 Previous Clinical Trials
1,065,477 Total Patients Enrolled
Clinical TrialsStudy DirectorHoffmann-La Roche
2,152 Previous Clinical Trials
873,094 Total Patients Enrolled

Eligibility Criteria

Age 5 - 64 · All Participants · 21 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a fever or symptoms of the flu, such as coughing, sore throat, congestion, headache, muscle or joint pain, or fatigue.

Who else is applying?

What state do they live in?
Texas44.4%
Alabama33.3%
North Carolina11.1%
Other11.1%
How old are they?
18 - 65100.0%
What site did they apply to?
Central Alabama Research; Pediatrics16.7%
Cahaba Research, Inc.33.3%
Long Beach Clinical Trials16.7%
Other33.3%
What portion of applicants met pre-screening criteria?
Met criteria62.5%
Did not meet criteria37.5%
How many prior treatments have patients received?
050.0%
3+50.0%
Why did patients apply to this trial?
  • "Prozac, anti depressants,"

How responsive is this trial?

Typically responds via
Phone Call100.0%
Most responsive sites:
  1. Cahaba Research, Inc.: < 24 hours
Average response time
  • < 1 Day

Frequently Asked Questions

Could you please give an estimate of how many people are being used as test subjects in this experiment?

"Yes, that is accurate. The listing on clinicaltrials.gov shows that this study began recruiting patients on October 10th, 2019 and is still ongoing. Currently, 3160 individuals are needed from a total of 41 sites." - Anonymous Online Contributor

Unverified Answer

Is this research the first to study this topic?

"Baloxavir Marboxil is being studied in 4 active clinical trials taking place in 91 cities and 26 countries. The first trial began in 2019 and was sponsored by Hoffmann-La Roche. Only 30 patients were needed for the Phase 3 drug approval stage. Since then, 18294 studies have been completed." - Anonymous Online Contributor

Unverified Answer

Are people still being signed up for this experiment?

"You're correct, the trial is recruiting patients right now. The listing on clinicaltrials.gov shows that the trial was posted on October 10th, 2019 and last updated October 27th, 2020." - Anonymous Online Contributor

Unverified Answer

Is this research being conducted with middle-aged adults?

"This trial's inclusion criteria includes a minimum age of 5 and a maximum age of 64." - Anonymous Online Contributor

Unverified Answer

How can I sign up to participate in this research project?

"Eligible individuals for this study are those that have influenza, are human, and between the ages of 5-64. A total of 3160 people are required for the study." - Anonymous Online Contributor

Unverified Answer

Are there any potential dangers in taking Baloxavir Marboxil?

"Baloxavir Marboxil is Phase 3, meaning that while there is data supporting efficacy, multiple rounds of data are needed to support safety." - Anonymous Online Contributor

Unverified Answer

In how many different geographical areas is this research being conducted?

"There are 41 trial sites currently operational, located in Mishawaka, Houston, Miami, and other locations." - Anonymous Online Contributor

Unverified Answer

What has been the general response to Baloxavir Marboxil in other scientific investigations?

"Currently, there are 4 ongoing trials investigating the efficacy of Baloxavir Marboxil. 3 of these trials are in Phase 3. Most of the clinical trials for Baloxavir Marboxil are located in Berazategui, Massachusetts; however, there are 350 total locations conducting studies on this medication." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.